A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation -- and pointing to a surprising new ally in the fight against type 2 diabetes.

Published Sept. 19 in Science Advances, the research reveals that pancreatic alpha cells, once thought to only produce glucagon -- a hormone that raises blood sugar to maintain energy when fasting or exercising -- also generate GLP-1, a powerful hormone that boosts insulin and helps regulate glucose. GLP-1 is the same hormone mimicked by blockbuster drugs like Ozempic and Mounjaro.

Using mass spectrometry, Duke researchers found that human alpha cells may naturally produce far more bioactive GLP-1 than previously believed.

Led by Duke scientist Jonathan Campbell, PhD, the team of obesity and diabetes researchers analyzed pancreatic tissue from both mice and humans across a range of ages, body weights, and diabetes statuses. They found that human pancreatic tissue produces much higher levels of bioactive GLP-1 and that this production is directly linked to insulin secretion.

"This research shows that alpha cells are more flexible than we imagined," said Campbell, an associate professor in the Division of Endocrinology in the Department of Medicine and a member of the Duke Molecular Physiology Institute. "They can adjust their hormone output to support beta cells and maintain blood sugar balance."

This flexibility could change how we think about treating type 2 diabetes, where beta cells in the pancreas can't make enough insulin to keep blood sugar at a healthy level. By boosting the body's own GLP-1 production, it may offer a more natural way to support insulin and manage blood sugar.

Switching gears

In mouse studies, when scientists blocked glucagon production, they expected insulin levels to drop. Instead, alpha cells switched gears -- ramping up GLP-1 production, improving glucose control, and triggering stronger insulin release.

"We thought that removing glucagon would impair insulin secretion by disrupting alpha-to-beta cell signaling," Campbell said. "Instead, it improved it. GLP-1 took over, and it turns out, it's an even better stimulator of insulin than glucagon."

To test this further, researchers manipulated two enzymes: PC2, which drives glucagon production, and PC1, which produces GLP-1. Blocking PC2 boosted PC1 activity and improved glucose control. But when both enzymes were removed, insulin secretion dropped and blood sugar spiked -- confirming the critical role of GLP-1.

Implications for diabetes treatment

While GLP-1 is typically made in the gut, the study confirms that alpha cells in the pancreas can also release GLP-1into the bloodstream after eating, helping to lower blood sugar by increasing insulin and reducing glucagon levels.

Common metabolic stressors, like a high-fat diet, can increase GLP-1 production in alpha cells -- but only modestly. That opens the door to future research: If scientists can find ways to safely boost GLP-1 output from alpha cells they may be able to naturally enhance insulin secretion in people with diabetes.

But measuring GLP-1 accurately hasn't been easy. The team developed a high-specificity mass spectrometry assay that detects only the bioactive form of GLP-1 -- the version that actually stimulates insulin -- not the inactive fragments that often muddy results.

"This discovery shows that the body has a built-in backup plan," Campbell said. "GLP-1 is simply a much more powerful signal for beta cells than glucagon. The ability to switch from glucagon to GLP-1 in times of metabolic stress may be a critical way the body maintains blood sugar control."

Additional authors: Canqi Cui, Danielle C. Leander, Sarah M. Gray, Kimberly El, Alex Chen, Paul Grimsrud, Guo-Fang Zhang, David A. D'Alessio, all of Duke; and Jessica O. Becker, Austin Taylor, Kyle W. Sloop, C. Bruce Verchere, and Andrew N. Hoofnagle,

Funding: National Institutes of Health, Canadian Institutes of Health Research, Borden Scholars, and Helmsley Charitable Trust Foundation.

Read more …Your pancreas may be making its own version of Ozempic

When German physicist Wilhelm Röntgen discovered X-rays in the late 1800s while experimenting with cathode ray tubes, it was a breakthrough that transformed science and medicine. So much so that the basic concept remains in use today. But a team of researchers at Sandia National Laboratories believes they've found a better way, harnessing different metals and the colors of light they emit.

"It's called colorized hyperspectral X-ray imaging with multi-metal targets, or CHXI MMT for short," said project lead Edward Jimenez, an optical engineer. Jimenez has been working with materials scientist Noelle Collins and electronics engineer Courtney Sovinec to create X-rays of the future.

"With this new technology, we are essentially going from the old way, which is black and white, to a whole new colored world where we can better identify materials and defects of interest," Collins said.

The team found they could achieve this using tiny, patterned samples of varied metals such as tungsten, molybdenum, gold, samarium and silver.

The Basics of X-ray Creation

To understand the concept, one must understand the basics of X-ray creation. Traditional X-rays are generated by bombarding a single metal target, or anode, with high-energy electrons. Those X-rays are channeled into a beam and directed at a subject or material. Denser tissues, like bone, absorb more X-rays, while less dense tissues, like muscles and organs allow more to pass through. A detector records the pattern, creating an image.

While X-ray technology has advanced over time, the basic concept remains the same, which limits resolution and clarity.

A New Type of X-Ray Image

The Sandia team set out to solve that limitation by making the X-ray focal spot smaller. The smaller the spot, the sharper the image.

They achieved this by designing an anode with metal dots patterned to be collectively smaller than the beam, effectively reducing the focal point.

But the team decided they wanted to push the limits and took the concept a step further.

"We chose different metals for each dot," Sovinec said. "Each metal emits a particular 'color' of X-ray light. When combined with an energy discriminating detector, we can count individual photons, which provide density information, and measure the energy of each photon. This allows us to characterize the elements of the sample."

The result is colorized images with what the team calls revolutionary image clarity and a better understanding of an object's composition.

"We get a more accurate representation of the shape and definition of that object, which is going to allow us to make unprecedented measurements and unprecedented observations," Jimenez said.

Far-reaching applications

The team sees this as a major advancement for X-ray technology with a wide range of uses, from airport security and quality control to nondestructive testing and advanced manufacturing.

They also hope its impact will improve medical diagnostics.

"With this technology, you can see even slight differences between materials," Jimenez said. "We hope this will help better identify things like cancer and more effectively analyze tumor cells. In mammography you are trying to catch something before it grows. In breast tissue, it's hard to identify the different dots, but with colorization you have a sharper beam and higher resolution image that increases the system's capability to detect a microcalcification. It's really exciting to be a part of that."

"From here we will continue to innovate," Collins said. "We hope to identify threats faster, diagnose diseases quicker and hopefully create a safer, healthier world."

The team was recently awarded an R&D 100 award for their technology. They were among six winners from Sandia. Click for R&D 100 Submission video with soundbites.

Read more …This stunning X-ray advance could help detect cancer earlier

Date:
Source:
American Chemical Society
Summary:
Researchers have created a two-stage acne patch with tiny arrowhead-shaped spikes that deliver healing compounds directly under the skin. Trials showed pimples vanished in seven days, and the technology may expand to treat other conditions.

FULL STORY


Clear Skin in a Week With New Acne Patch
This new pimple patch features a specialized array of tiny spikes to help deliver acne-busting compounds under the skin. Credit: Adapted from ACS Applied Materials & Interfaces 2025, DOI: 10.1021/acsami.5c07718

Waking up with a pimple is no longer cause for panic, thanks to pimple patches -- small, sticker-like bandages that cover and help heal the unwanted zit. A team of researchers publishing in ACS Applied Materials & Interfaces has designed a two-stage pimple patch set with an array of tiny spikes that grabs onto the pimple and delivers antibacterial or anti-inflammatory compounds. Human clinical trials confirmed that the pimples completely disappeared after seven days of treatment.

Also called acne stickers, pimple patches are made of polymers that absorb excess moisture and oil. Some versions contain medications that reduce inflammation or fight infection. These medicated stickers often use microarrays (rows of teensy spikes) that penetrate the skin's outermost layer and deliver compounds underneath. But microarrays may shift during wear and irritate the skin. So, Shayan Fakhraei Lahiji, Yong-Hee Kim and colleagues wanted to design a medicated acne patch system with a microarray platform that stays put.

To create their patch, the researchers first printed a microarray of arrowhead-shaped spikes using a specialized 3D printer. This unique shape helped the patch lock in place when attached to the skin. The patch's backbone is made of hyaluronic acid -- a gooey polymer that's a common skincare ingredient -- that was mixed with either antibacterial agents (including salicylic acid and Cannabis sativa extract) or anti-inflammatory agents (including niacinamide and chamomile extract).

These patches were clinically tested on 20 participants. On the first day, the participants applied the antibacterial patch, and for the next six days, they applied a new anti-inflammatory patch. The hyaluronic acid-based microarray dissolved into the skin within 30 to 90 minutes, with no pain or irritation. After three days, participants noted an 81% reduction in acne lesions in the treated areas compared to untreated pimples, and after seven days, the treated pimples were gone altogether. Additionally, researchers noted a significant reduction in sebum -- an oily substance that causes acne. Around 95% of participants report that they were satisfied with the results of the treatment.

The researchers plan to make their new patch available for purchase in fall 2025, in both South Korea and the United States. In addition, the technology could be reformulated to deliver other therapies, beyond just acne-fighting compounds.

"Our work highlights the potential of microarray patches as a platform for applications beyond acne treatment, ranging from skin disorders to obesity therapies and vaccine delivery," explains Kim.

The authors acknowledge funding from the Technology Development Program of the Korean Ministry of SMEs and Startups; the Korea Health Technology R&D Project through the Korea Health Industry Development Institute; and the Korean Ministry of Health & Welfare.

The authors are employees of Cursus Bio Inc., a company focusing on microarray-based technologies.


Story Source:

Materials provided by American Chemical Society. Note: Content may be edited for style and length.


Journal Reference:

  1. Jisook Park, Jaehyun Kim, Shayan Fakhraei Lahiji, Yong-Hee Kim. Dual-Phase Antibacterial and Anti-inflammatory Self-Locking Microarray Patches for the Effective Treatment of Acne Vulgaris. ACS Applied Materials, 2025; 17 (32): 45438 DOI: 10.1021/acsami.5c07718[1]

Cite This Page:

American Chemical Society. "Clear skin in a week with this breakthrough acne patch." ScienceDaily. ScienceDaily, 20 September 2025. <www.sciencedaily.com/releases/2025/09/250919085250.htm>.

American Chemical Society. (2025, September 20). Clear skin in a week with this breakthrough acne patch. ScienceDaily. Retrieved September 20, 2025 from www.sciencedaily.com/releases/2025/09/250919085250.htm

American Chemical Society. "Clear skin in a week with this breakthrough acne patch." ScienceDaily. www.sciencedaily.com/releases/2025/09/250919085250.htm (accessed September 20, 2025).

RELATED STORIES


Study Shows That 'Super Spikes' Can Increase Track Running Speed by 2%[2]

Sep. 4, 2024 — Research shows that super spikes, scientifically described as advanced footwear technology (AFT) spikes, can give runners about a 2% edge in middle-distance track races, like the 800- and ...

Wearing Your Heart (Monitor) on Your Sleeve[3]

Oct. 31, 2023 — By detecting cardiovascular ailments and helping assess overall cardiac health, wearable electrocardiograms save lives, not to mention exorbitant hospital care costs. Researchers now present a novel ...

NUS Scientists Develop Innovative Magnetic Gel That Heals Diabetic Wounds Three Times Faster[4]

Oct. 19, 2023 — A team of researchers has engineered an innovative magnetic wound-healing gel that promises to heal diabetic wounds three times faster, reduce the rates of recurrence, and in turn, lower the ...

Innovative Paper-Like, Battery-Free, AI-Enabled Sensor for Holistic Wound Monitoring[5]

June 26, 2023 — Scientists have invented a paper-like, battery-free, AI-enabled sensor patch -- PETAL -- for convenient and effective monitoring of wound recovery. This novel technology provides early warning of ...

Not All Acne Is Equal: Scientists Reveal Strains of C. Acnes That Promote Skin Health[6]

Oct. 27, 2021 — Researchers reveal correlation between ribotype (RT) strains of Cutibacterium acnes, which are found in human skin, and the lifespan of the nematode Caenorhabditis elegans. Strains RT4 and 8, which ...

Microneedle Patch Delivers Antibiotics Locally in the Skin[7]

May 10, 2021 — MRSA skin infections are often treated with intravenous injection of antibiotics, which can cause significant side effects and promote the development of resistant bacterial strains. To solve these ...

TRENDING AT SCITECHDAILY.com[8]


A New Hope for Life? Webb Telescope Reveals First Clues From Potentially Habitable World[9]

Is the Keto Diet Sexist? Research Reveals Stark Differences in How Male and Female Bodies Respond[10]

New Pill for Obesity Delivers Major Weight Reduction Without Injections[11]

Ultra-Processed Foods Aren’t the Villain You Think They Are, Scientists Reveal[12]

Read more …Clear skin in a week with this breakthrough acne patch

In the U.S., one in five of the 37 million adults who has diabetes doesn't know it. Current methods of diagnosing diabetes and prediabetes usually require a visit to a doctor's office or lab work, both of which can be expensive and time-consuming. Now, diagnosing diabetes and prediabetes may be as simple as breathing.

A research team led by Huanyu "Larry" Cheng, James L. Henderson, Jr. Memorial Associate Professor of Engineering Science and Mechanics at Penn State, has developed a sensor that can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample. Their results were published in Chemical Engineering Journal.

Previous diagnostic methods often used glucose found in blood or sweat, but this sensor detects acetone levels in the breath. While everyone's breath contains acetone as a byproduct of burning fat, acetone levels above a threshold of about 1.8 parts per million indicate diabetes.

"While we have sensors that can detect glucose in sweat, these require that we induce sweat through exercise, chemicals or a sauna, which are not always practical or convenient," Cheng said. "This sensor only requires that you exhale into a bag, dip the sensor in and wait a few minutes for results."

Cheng said there have been other breath analysis sensors, but they detected biomarkers that required lab analysis. Acetone can be detected and read on-site, making the new sensors cost-effective and convenient.

In addition to using acetone as the biomarker, Cheng said another novelty of the sensor came down to design and materials -- primarily laser-induced graphene. To create this material, the CO2 laser is used to burn the carbon-containing materials, such as the polyimide film in this work, to create patterned porous graphene with large defects desirable for sensing.

"This is similar to toasting bread to carbon black if toasted too long," Cheng said. "By tuning the laser parameters such as power and speed, we can toast polyimide into few-layered, porous graphene form."

The researchers used laser-induced graphene because it is highly porous, meaning it lets gas through. This quality leads to a greater chance of capturing the gas molecule, since breath exhalation contains a relatively high concentration of moisture. However, by itself, the laser-induced graphene was not selective enough of acetone over other gases and needed to be combined with zinc oxide.

"A junction formed between these two materials that allowed for greater selective detection of acetone as opposed to other molecules," Cheng said.

Cheng said another challenge was that the sensor surface could also absorb water molecules, and because breath is humid, the water molecules could compete with the target acetone molecule. To address this, the researchers introduced a selective membrane, or moisture barrier layer, that could block water but allow the acetone to permeate the layer.

Cheng said that right now, the method requires that a person breathe directly into a bag to avoid interference from factors such as airflow in the ambient environment. The next step is to improve the sensor so that it can be used directly under the nose or attached to the inside of a mask, since the gas can be detected in the condensation of the exhaled breath. He said he also plans to investigate how an acetone-detecting breath sensor could be used to optimize health initiatives for individuals.

"If we could better understand how acetone levels in the breath change with diet and exercise, in the same way we see fluctuations in glucose levels depending on when and what a person eats, it would be a very exciting opportunity to use this for health applications beyond diagnosing diabetes," Cheng said.

Funding from the U.S. National Institutes of Health and the U.S. National Science Foundation supported the Penn State contributions to this work. Li Yang, who was a visiting scholar in the Penn State Department of Engineering Science and Mechanics at the time of the research, is the first author. A full list of funding and authors can be found in the paper.

Read more …New breath sensor detects diabetes quickly and easily

More Articles …